SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-028201
Filing Date
2022-11-03
Accepted
2022-11-03 16:15:19
Documents
77
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xfor-20220930.htm   iXBRL 10-Q 1681532
2 EX-31.1 ex-311q32022.htm EX-31.1 9361
3 EX-31.2 ex-312q32022.htm EX-31.2 9353
4 EX-32.1 ex-321q32022.htm EX-32.1 7074
10 xfor-20220930_g1.jpg GRAPHIC 122311
  Complete submission text file 0001628280-22-028201.txt   7424500

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20220930.xsd EX-101.SCH 54208
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xfor-20220930_cal.xml EX-101.CAL 60687
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xfor-20220930_def.xml EX-101.DEF 195833
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20220930_lab.xml EX-101.LAB 583976
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20220930_pre.xml EX-101.PRE 383540
71 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20220930_htm.xml XML 1146786
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38295 | Film No.: 221358190
SIC: 2836 Biological Products, (No Diagnostic Substances)